article thumbnail

STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more

STAT

As of last October, the agency had received more than 500 drug submissions with AI components going back to 2016, with a large number in the areas of oncology, neurology, and gastroenterology.   Most of the compounds came from commonly prescribed medications including antidepressants and statins.

FDA 100
article thumbnail

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. In 2016, Ionis won approval for an infusion called Spinraza.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Reasons People Fail The NAPLEX, Revisited

IDStewardship

In 2016 a pharmacy professor developed a blog post about five reasons why people fail the NAPLEX. Curious to read the article about why people fail the NAPLEX from 2016? Now years later, he revisits the topic here. Authored By: Christopher Bland, Pharm.D., I often in return get a lot of blank stares as they have never heard of them.

article thumbnail

Manual IV Compounding – a Potential Recipe for Disaster?

Omnicell

When we talked about IV room compounding, I’ll never forget them telling me, “Making IVs is not like making pizzas at the local sub shop.” ” It’s not a big deal if you mix up sausage and pepperoni on a pizza, but one misstep in manual IV compounding could be absolutely devastating to a patient.

article thumbnail

MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO

pharmaphorum

Founded in 2016 by husband and wife entrepreneur team George Goldsmith and Ekaterina Malievskaia, Compass is already backed by investors including PayPal co-founder Peter Thiel and German entrepreneur Christian Angermayer. million with its IPO on Friday and shares are still significantly above their launch price of $17.

article thumbnail

Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technology

pharmaphorum

Owlstone is developing a breath-based analyser that captures Volatile Organic Compounds (VOCs) in breath non-invasively, and analyses them with high sensitivity. After recognising the potential of the technology to be applied in healthcare, Boyle spun Owlstone Medical out in 2016 and now has a a team of over 170 people.

article thumbnail

How to Use Cranberry Juice for UTIs

The People's Pharmacy

Separate research indicates that cranberries get their anti-infective power from polyphenol compounds called proanthocyanidins. However, these cranberry compounds potentiated the effectiveness of several commonly used antibiotics. First, the compounds help antibiotics penetrate the bacterial cell membranes. 26, 2016 ).